The drug’s Phase 3 results are comparable to those of Trodelvy, a TROP2-targeting ADC marketed by Gilead Sciences as a second-line treatment for HR positive, HER2 negative breast cancer ...

Milio is now on the live servers, so let’s check out which are the best ADC champions to play alongside him in the current LoL meta. Milio is one of the newest support of League of Legends, as he set ...

Bot Lane diversity in League of Legends has expanded to include marksmen, mages, and fighters, providing more strategic options. The best Bot Laners are subject to frequent meta shifts due to ...